Table 4: Association of echocardiographic abnormalities with CD4+ T cell count.
|
Echocardiographic abnormality |
Group A (≥ 500) |
Group B (350-499 ) |
Group C (200- 349) |
Group D (100- 199) |
GroupE (< 100) |
Mean ± SD |
|
RWMA (n = 14) |
0 |
1 |
6 |
3 |
4 |
197.07 ± 115.25 |
|
Pulmonary hypertension (n = 12) |
0 |
1 |
0 |
4 |
7 |
115.08 ± 89.8 |
|
Pulmonary thromboembolism (n = 2) |
0 |
1 |
0 |
0 |
1 |
220 ± 197.99 |
|
LVH (n = 11) |
0 |
4 |
5 |
1 |
1 |
313.36 ± 131.68 |
|
Pericardial effusion (n = 26) |
0 |
2 |
5 |
11 |
8 |
156.04 ± 104.96 |
|
Cardiomyopathy (n = 13) |
0 |
0 |
1 |
5 |
7 |
97.92 ± 53.6 |
|
Diastolic dysfunction (n = 64) |
1 |
9 |
15 |
14 |
25 |
141.24 ± 118.99 |
|
Valvular insufficiency (n = 42) |
0 |
4 |
6 |
10 |
22 |
211.76 ± 214.41 |
|
Reduced LVEF (n = 30) |
0 |
0 |
7 |
8 |
15 |
123.2 ± 85.43 |
|
Others (n = 2) |
0 |
0 |
1 |
1 |
0 |
184 ± 59.4 |
|
P value |
< 0.0001 |
0.001 |
||||